FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387206485> ?p ?o ?g. }

• W4387206485 endingPage "e64" @default.
• W4387206485 startingPage "e64" @default.
• W4387206485 abstract "Brachytherapy (BT) improves clinical outcomes among women with cervical and endometrial cancers. Recent trends found decreasing BT rates in the United States; however, racial/ethnic differences have not been investigated completely. Here we aim to analyze 1) variations in BT practice patterns, 2) racial differences of BT, and 3) predictors of BT by race among women with cervical and endometrial cancers in the United States.A retrospective cohort of women with endometrial and cervical cancers in the US was evaluated using the National Cancer Database, between 2004 and 2017. Primary endpoint was treatment with BT. Women ≥18 years of age were included for FIGO Stage IA-IVA, non-surgically treated cervical cancers and high intermediate risk (PORTEC-2 and GOG-99 definition) or FIGO Stage II-IVA endometrial cancers. Racial groups were in accordance with federal guidelines including Asian, American Indian and Alaska Native (AIAN), Black, Native Hawaiian and other Pacific Islander (NHPI), and White. BT practice patterns and trends over time were evaluated by race. To identify predictors of BT by race, logistic regression calculated adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) after assessing for multicollinearity.A total of 13,857 women with cervical cancer and 140,942 women with endometrial cancer were included. Median follow-up was 69 months. Median (IQR) age was 53 (43-63) years for cervical cancer and 64 (57-72) years for endometrial cancer. Most cervical cancers were Stage III (44%), squamous cell carcinoma (88%), and lymphovascular space invasion (LVSI) positive (49%). Most endometrial cancers were Stage IB (45%), endometrioid histology (82%), and LVSI-positive (50%). Between 2004 and 2017, endometrial cancer BT increased (34% to 57%). BT rates for cervical cancer ranged from 65% NHPI, 63% Asian, 62% White, 59% AIAN, and 57% Black. BT rates for endometrial cancer ranged from 26% Black, 25% White, 25% Asian, 21% AIAN, and 20% NHPI. By race, only Black women with cervical cancer were significantly less likely to receive BT (aOR = 0.8; 95% CI = 0.7-0.9), compared to White women. Only NHPI women with endometrial cancer were less likely to receive BT (aOR = 0.7; 95% CI = 0.5-1.0), compared to White women. Community cancer center treatment was the only factor associated with a decreased odds of BT for both Black women with cervical cancer (aOR = 0.7; 95% CI = 0.6-0.9) and NHPI women with endometrial cancer (aOR = 0.3; 95% CI = 0.1-0.8), compared to academic centers.In this study of women diagnosed with endometrial and cervical cancers with stages known to benefit from BT, NHPI women with endometrial cancer and Black women with cervical cancer were less likely to receive brachytherapy compared to White women. Community engagement is needed to increase BT access for patients treated at community cancer centers to ensure equitable gynecologic cancer care." @default.
• W4387206485 created "2023-09-30" @default.
• W4387206485 creator A5008027539 @default.
• W4387206485 creator A5026710549 @default.
• W4387206485 creator A5028868514 @default.
• W4387206485 creator A5030621467 @default.
• W4387206485 creator A5033542764 @default.
• W4387206485 creator A5051786602 @default.
• W4387206485 creator A5056024130 @default.
• W4387206485 creator A5057141823 @default.
• W4387206485 creator A5073413027 @default.
• W4387206485 date "2023-10-01" @default.
• W4387206485 modified "2023-10-17" @default.
• W4387206485 title "Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancers: A United States Cohort Study between 2004 and 2017" @default.
• W4387206485 doi "https://doi.org/10.1016/j.ijrobp.2023.06.787" @default.
• W4387206485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37785907" @default.
• W4387206485 hasPublicationYear "2023" @default.
• W4387206485 type Work @default.
• W4387206485 citedByCount "0" @default.
• W4387206485 crossrefType "journal-article" @default.
• W4387206485 hasAuthorship W4387206485A5008027539 @default.
• W4387206485 hasAuthorship W4387206485A5026710549 @default.
• W4387206485 hasAuthorship W4387206485A5028868514 @default.
• W4387206485 hasAuthorship W4387206485A5030621467 @default.
• W4387206485 hasAuthorship W4387206485A5033542764 @default.
• W4387206485 hasAuthorship W4387206485A5051786602 @default.
• W4387206485 hasAuthorship W4387206485A5056024130 @default.
• W4387206485 hasAuthorship W4387206485A5057141823 @default.
• W4387206485 hasAuthorship W4387206485A5073413027 @default.
• W4387206485 hasConcept C121608353 @default.
• W4387206485 hasConcept C126322002 @default.
• W4387206485 hasConcept C131872663 @default.
• W4387206485 hasConcept C143998085 @default.
• W4387206485 hasConcept C146357865 @default.
• W4387206485 hasConcept C151730666 @default.
• W4387206485 hasConcept C156957248 @default.
• W4387206485 hasConcept C167135981 @default.
• W4387206485 hasConcept C2777088508 @default.
• W4387206485 hasConcept C2777416452 @default.
• W4387206485 hasConcept C2778220009 @default.
• W4387206485 hasConcept C2908647359 @default.
• W4387206485 hasConcept C29456083 @default.
• W4387206485 hasConcept C3020641676 @default.
• W4387206485 hasConcept C509974204 @default.
• W4387206485 hasConcept C71924100 @default.
• W4387206485 hasConcept C72563966 @default.
• W4387206485 hasConcept C86803240 @default.
• W4387206485 hasConcept C99454951 @default.
• W4387206485 hasConceptScore W4387206485C121608353 @default.
• W4387206485 hasConceptScore W4387206485C126322002 @default.
• W4387206485 hasConceptScore W4387206485C131872663 @default.
• W4387206485 hasConceptScore W4387206485C143998085 @default.
• W4387206485 hasConceptScore W4387206485C146357865 @default.
• W4387206485 hasConceptScore W4387206485C151730666 @default.
• W4387206485 hasConceptScore W4387206485C156957248 @default.
• W4387206485 hasConceptScore W4387206485C167135981 @default.
• W4387206485 hasConceptScore W4387206485C2777088508 @default.
• W4387206485 hasConceptScore W4387206485C2777416452 @default.
• W4387206485 hasConceptScore W4387206485C2778220009 @default.
• W4387206485 hasConceptScore W4387206485C2908647359 @default.
• W4387206485 hasConceptScore W4387206485C29456083 @default.
• W4387206485 hasConceptScore W4387206485C3020641676 @default.
• W4387206485 hasConceptScore W4387206485C509974204 @default.
• W4387206485 hasConceptScore W4387206485C71924100 @default.
• W4387206485 hasConceptScore W4387206485C72563966 @default.
• W4387206485 hasConceptScore W4387206485C86803240 @default.
• W4387206485 hasConceptScore W4387206485C99454951 @default.
• W4387206485 hasIssue "2" @default.
• W4387206485 hasLocation W43872064851 @default.
• W4387206485 hasLocation W43872064852 @default.
• W4387206485 hasOpenAccess W4387206485 @default.
• W4387206485 hasPrimaryLocation W43872064851 @default.
• W4387206485 hasRelatedWork W2384708512 @default.
• W4387206485 hasRelatedWork W2404243584 @default.
• W4387206485 hasRelatedWork W2409536117 @default.
• W4387206485 hasRelatedWork W2966036943 @default.
• W4387206485 hasRelatedWork W3029595631 @default.
• W4387206485 hasRelatedWork W3104537559 @default.
• W4387206485 hasRelatedWork W4205904040 @default.
• W4387206485 hasRelatedWork W4206581437 @default.
• W4387206485 hasRelatedWork W4239216562 @default.
• W4387206485 hasRelatedWork W4246030040 @default.
• W4387206485 hasVolume "117" @default.
• W4387206485 isParatext "false" @default.
• W4387206485 isRetracted "false" @default.
• W4387206485 workType "article" @default.